356 related articles for article (PubMed ID: 25126899)
1. Colorectal cancer detection using targeted serum metabolic profiling.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
[TBL] [Abstract][Full Text] [Related]
2. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
[TBL] [Abstract][Full Text] [Related]
3. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
4. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
10. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
[TBL] [Abstract][Full Text] [Related]
11. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling.
Djukovic D; Zhang J; Raftery D
Methods Mol Biol; 2018; 1765():229-240. PubMed ID: 29589312
[TBL] [Abstract][Full Text] [Related]
13. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
14. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
Chen L; Zhang C; Gui Q; Chen Y; Yang Y
Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
[TBL] [Abstract][Full Text] [Related]
15. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
[TBL] [Abstract][Full Text] [Related]
16. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
18. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
[TBL] [Abstract][Full Text] [Related]
20. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
